The genus Dickeya is an important group of plant pathogens that currently comprises eight
recognized species. Although most Dickeya isolates originated from infected cultivated plants…

A key challenge in the clinical proteomics of cancer is the identification of biomarkers that
would enable early detection, diagnosis and monitoring of disease progression to improve long…

3 Garcia-Sanz R, Orfao A, Gonzalez M et al. Primary plasma cell leukemia: clinical,
immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood 1999; 93: 1032–7. 4 Osanto S…

Background Insulin-like growth factors (IGF-1 and IGF-2) bind to the IGF-1 receptor (IGF-1R),
increasing cell proliferation and survival. Ganitumab is a monoclonal IgG1 antibody that …

Eribulin mesylate (EM) was recently approved for metastatic breast cancer (MBC)
chemotherapy (CT) in late lines by the FDA, with debated results in second line. We evaluated …

Variations in clinical response to tamoxifen (TAM) may be related to polymorphic cytochromes
P450 (CYPs) involved in forming its active metabolite endoxifen (ENDO). We developed a …

Background We aimed to describe, among a population of women with intellectual disabilities
(ID) living in institutions in France, the characteristics in whom breast cancer (BC) was …

… Eighteen centres in France and Italy invited patients with BC who had at least one teleconsultation
during the first wave of the COVID-19 pandemic to participate in a web-based survey …

Most high‐grade ovarian carcinomas (HGOCs) are sensitive to carboplatin (CBP)‐based
chemotherapy but frequently recur within 24 months. Recurrent tumors remain CBP‐sensitive …

Cancer progression is driven in part by genomic alterations 1 . The genomic characterization
of cancers has shown interpatient heterogeneity regarding driver alterations 2 , leading to …